Low-Dose Anticoagulation for Atrial Fibrillation: When Is a Floor a Trap Door?

Halperin, Jonathan L; Rashed, Eman R

Halperin, Jonathan L; Rashed, Eman R.

Affiliation

Halperin JL; Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, USA. Electronic address: jonathan.halperin@mssm.edu.
Rashed ER; Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, USA.

J Am Coll Cardiol ; 77(9): 1208-1210, 2021 03 09.

Article in En | MEDLINE | ID: mdl-33663738

Subject(s)

Atrial Fibrillation; Anticoagulants; Atrial Fibrillation/complications; Atrial Fibrillation/drug therapy; Blood Coagulation; Humans; Warfarin

Key words

DOAC; anticoagulation; atrial fibrillation; warfarin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Atrial Fibrillation Limits: Humans Language: En Journal: J Am Coll Cardiol Year: 2021 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Atrial Fibrillation Limits: Humans Language: En Journal: J Am Coll Cardiol Year: 2021 Type: Article